Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Receivables - Net: 2023-2025

Historic Receivables - Net for Upstream Bio (UPB) over the last 1 years, with Sep 2025 value amounting to $683,000.

  • Upstream Bio's Receivables - Net rose 12.52% to $683,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $683,000, marking a year-over-year increase of 12.52%. This contributed to the annual value of $613,000 for FY2024, which is 525.51% up from last year.
  • According to the latest figures from Q3 2025, Upstream Bio's Receivables - Net is $683,000, which was down 27.11% from $937,000 recorded in Q2 2025.
  • In the past 5 years, Upstream Bio's Receivables - Net ranged from a high of $937,000 in Q2 2025 and a low of $98,000 during Q4 2023.
  • For the 3-year period, Upstream Bio's Receivables - Net averaged around $543,429, with its median value being $607,000 (2024).
  • Data for Upstream Bio's Receivables - Net shows a peak YoY soared of 525.51% (in 2024) over the last 5 years.
  • Over the past 3 years, Upstream Bio's Receivables - Net (Quarterly) stood at $98,000 in 2023, then soared by 525.51% to $613,000 in 2024, then increased by 12.52% to $683,000 in 2025.
  • Its last three reported values are $683,000 in Q3 2025, $937,000 for Q2 2025, and $566,000 during Q1 2025.